The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Chronic Renal Insufficiency Cohort (CRIC) Study: Baseline Characteristics and Associations with Kidney Function
Open accessAbstract
BACKGROUND AND OBJECTIVES: The Chronic Renal Insufficiency Cohort (CRIC) Study was established to examine risk factors for the progression of chronic kidney disease (CKD) and cardiovascular disease (CVD) in patients with CKD. We examined baseline demographic and clinical characteristics. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Seven clinical centers recruited adults who were aged 21 to 74 yr and had CKD using age-based estimated GFR (eGFR) inclusion criteria. At baseline, blood and urine specimens were collected and information regarding health behaviors, diet, quality of life, and functional status was obtained. GFR was measured using radiolabeled iothalamate in one third of participants. RESULTS: A total of 3612 participants were enrolled with mean age +/- SD of 58.2 +/- 11.0 yr; 46% were women, and 47% had diabetes. Overall, 45% were non-Hispanic white, 46% were non-Hispanic black, and 5% were Hispanic. Eighty-six percent reported hypertension, 22% coronary disease, and 10% heart failure. Mean body mass index was 32.1 +/- 7.9 kg/m(2), and 47% had a BP >130/80 mmHg. Mean eGFR was 43.4 +/- 13.5 ml/min per 1.73 m(2), and median (interquartile range) protein excretion was 0.17 g/24 h (0.07 to 0.81 g/24 h). Lower eGFR was associated with older age, lower socioeconomic and educational level, cigarette smoking, self-reported CVD, peripheral arterial disease, and elevated BP. CONCLUSIONS: Lower level of eGFR was associated with a greater burden of CVD as well as lower socioeconomic and educational status. Long-term follow-up of participants will provide critical insights into the epidemiology of CKD and its relationship to adverse outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Difficulty controlling BP in late stages of CKD was also seen in CRIC (Chronic Renal Insufficiency Cohort), in which 88% of participants had stage 3 or 4 CKD.”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [302]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation
Beck, A. T., Steer, R. A., & Carbin, M. G. (1988) · Clinical Psychology Review · doi:10.1016/0272-7358(88)90050-5 · Cited by 11,696
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Self-citationChronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Self-citationBrenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
Self-citationMulti-Ethnic Study of Atherosclerosis: Objectives and Design
Bild, D. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf113 · Cited by 3,942
Flagged first, then by citations
1 of the 52 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 619
Al‐Qaoud, T., Nitsch, D., Wells, J. C. K., Witte, D. R., & Brunner, E. J. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.04.017 · Cited by 45
“Losses to follow-up are inevitable in longitudinal cohorts, and our participants were gathered from a sample representing 67% of the original cohort size (10,308).”
BackgroundCardiovascular Disease Consequences of CKD
Go, A. S. (2016) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2016.05.006 · Cited by 45
Self-citationKang, E., Han, M., Kim, H., Park, S.-K., Lee, J., Hyun, Y., Kim, Y.-S., Chung, W., Kim, H., Oh, Y., et al. (2016) · Journal of Korean medical science · doi:10.3346/jkms.2017.32.2.221 · Cited by 38
“The subjects in the CRIC study are more obese and more likely to have diabetes at enrollment than those in the KNOW-CKD.”
BackgroundInfluentialThe KNOW-CKD Study: What we have learned about chronic kidney diseases
Oh, K., Kang, M., Kang, E., Ryu, H., Han, S. H., Yoo, T., Kim, S. W., Chae, D., Lee, K., Park, S. K., et al. (2020) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.20.042 · Cited by 45
“Unlike other CKD cohort studies such as the Chronic Renal Insufficiency Cohort (CRIC) of the United States [6,7] or the Chronic Kidney Disease Japan Cohort (CKD-JAC) of Japan [8], the KNOW-CKD study includes CKD at early stages (stages G1 and G2) as well as advanced stages, providing a platform on…”
Ku, E., McCulloch, C. E., Adey, D., Li, L., & Johansen, K. L. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020081144 · Cited by 45
Sullivan, V. K., Appel, L. J., Anderson, C. A. M., Kim, H., Unruh, M. L., Lash, J. P., Trego, M. L., Sondheimer, J., Dobre, M. A., Pradhan, N., et al. (2023) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2023.01.452 · Cited by 48
Self-citationGenomic biomarkers for chronic kidney disease
Ju, W., Smith, S., & Kretzler, M. (2012) · Translational research · doi:10.1016/j.trsl.2012.01.020 · Cited by 43
Time-Centered Approach to Understanding Risk Factors for the Progression of CKD
Ku, E., Johansen, K. L., & McCulloch, C. E. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10360917 · Cited by 43
Variations in 24-Hour BP Profiles in Cohorts of Patients with Kidney Disease around the World
Drawz, P. E., Brown, R. Z., Nicola, L. D., Fujii, N., Gabbai, F. B., Gassman, J., He, J., Iimuro, S., Lash, J. P., Minutolo, R., et al. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.13181117 · Cited by 43
Self-citationBansal, N., Zelnick, L. R., Scherzer, R., Estrella, M. M., & Shlipak, M. G. (2024) · Circulation Heart Failure · doi:10.1161/circheartfailure.123.011173 · Cited by 44
Global Burden of Diabetes Mellitus
Perianayagam, A., Salvi, S., & Selvamani, Y. (2021) · Springer eBooks · doi:10.1007/978-3-030-05325-3_28-2 · Cited by 54
Green, J. A., & Cavanaugh, K. L. (2015) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.07.004 · Cited by 40
Wang, G. J., Shaw, P. A., Townsend, R. R., Anderson, A. H., Xie, D., Wang, X. L., Nessel, L. C., Mohler, E. R., Sozio, S. M., Jaar, B. G., et al. (2016) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.115.002180 · Cited by 40
Self-citationAcid Load and Phosphorus Homeostasis in CKD
Khairallah, P., Isakova, T., Asplin, J. R., Hamm, L. L., Dobre, M. A., Rahman, M., Sharma, K., Leonard, M. B., Miller, E. R., Jaar, B. G., et al. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.04.022 · Cited by 40
Self-citationBP Measurement in Clinical Practice: Time to SPRINT to Guideline-Recommended Protocols
Drawz, P. E., & Ix, J. H. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017070753 · Cited by 39
Orlandi, P., Xie, D., Yang, W. P., Cohen, J. B., Deo, R., Ricardo, A. C., Schrauben, S. J., Wang, X., Hamm, L. L., He, J., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020040476 · Cited by 40
Self-citationKalim, S., Berg, A. H., Karumanchi, S. A., Thadhani, R., Allegretti, A. S., Nigwekar, S. U., Zhao, S. J., Srivastava, A., Raj, D. S., Deo, R., et al. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa347 · Cited by 40
Self-citationBansal, N., Zelnick, L. R., Ballantyne, C. M., Chaves, P. H. M., Christenson, R. H., Coresh, J., deFilippi, C. R., de Lemos, J. A., Daniels, L. B., Go, A. S., et al. (2021) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.06.017 · Cited by 40
Self-citationHecking, M., Tu, C., Zee, J., Bieber, B. A., Hödlmoser, S., Reichel, H., Sesso, R., Port, F. K., Robinson, B. M., Carrero, J. J., et al. (2021) · Kidney International Reports · doi:10.1016/j.ekir.2021.11.018 · Cited by 40
Chapter 5: Referral to specialists and models of care
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.68 · Cited by 42
Chen, J., Mohler, E. R., Garimella, P. S., Hamm, L. L., Xie, D., Kimmel, S., Townsend, R. R., Budoff, M. J., Pan, Q., Nessel, L. A., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003339 · Cited by 39
“The design and baseline characteristics of the CRIC Study participants have been previously described.(9,10) Briefly, the CRIC Study enrolled a racially and ethnically diverse group of men and women ages 21 to 74 years with CKD as determined by an age-based estimated glomerular filtration rate (eGFR) of 20 to 70 mL/mi…”
MethodSelf-citationInflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney Disease
Chen, J., Bundy, J. D., Hamm, L. L., Hsu, C., Lash, J. P., Miller, E. R., Thomas, G., Cohen, D. L., Weir, M. R., Raj, D. S., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12358 · Cited by 39
Self-citationLin, H.-T., Zheng, C., Wu, Y., Chang, Y., Chen, J.-T., Liang, C.-M., Chang, T.-J., Zheng, J.-Q., Tai, M., & Lin, Y. (2019) · Nutrients · doi:10.3390/nu11030509 · Cited by 39
Impact of AKI on Urinary Protein Excretion: Analysis of Two Prospective Cohorts
Hsu, C., Hsu, R. K., Liu, K. D., Yang, J., Anderson, A., Chen, J., Chinchilli, V. M., Feldman, H. I., Garg, A. X., Hamm, L. L., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018101036 · Cited by 39
Self-citationCardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study
Lamprea-Montealegre, J. A., Zelnick, L. R., Shlipak, M. G., Floyd, J. S., Anderson, A. H., He, J., Christenson, R. H., Seliger, S. L., Soliman, E. Z., Deo, R., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012200 · Cited by 38
“DOI: 10.1161/JAHA.119.012200 Journal of the American Heart Association 7 Atrial Fibrillation Biomarkers in CKD Lamprea-Montealegre et al O R IG IN A L R E S E A R C H to additional questions about whether novel therapies that directly affect cardiorenal outcomes may be effective in decreasing the risk of AF in patient…”
InfluentialSelf-citationPPARγ and Its Agonists in Chronic Kidney Disease
Ma, Y., Shi, M., Wang, Y., & Liu, J. (2020) · International Journal of Nephrology · doi:10.1155/2020/2917474 · Cited by 42
“In CRIC study, the prevalence of hypertension was 86%, much higher than the general population [81].”
Background(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.72 · Cited by 39
Mehta, R. C., Cho, M. E., Cai, X., Lee, J. J., Chen, J., He, J., Flack, J. M., Shafi, T., Saraf, S. L., David, V., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.07.013 · Cited by 40
Self-citationZhang, X., Bansal, N., Go, A. S., & Hsu, C. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0209-z · Cited by 38
“Finally, CRIC excluded patients with polycystic kidney disease, multiple myeloma and glomerular diseases on active immunosuppression [14, 15].”
BackgroundMethodSelf-citationEder, S., Leierer, J., Kerschbaum, J., Rosivall, L., Więcek, A., de Zeeuw, D., Mark, P. B., Heinze, G., Rossing, P. R., Heerspink, H. J. L., et al. (2018) · Kidney & Blood Pressure Research · doi:10.1159/000487500 · Cited by 38
Villain, C., Metzger, M., Combe, C., Fouque, D. P., Frimat, L., Jacquelinet, C., Laville, M., Briançon, S., Klein, J., Schanstra, J. P., et al. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy277 · Cited by 38
Neves, J. S., Correa, S., Baptista, R. B., Vieira, M. B., Waikar, S. S., & Causland, F. R. M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa017 · Cited by 40
Hsu, R. K., Chai, B., Roy, J. A., Anderson, A. H., Bansal, N., Feldman, H. I., Go, A. S., He, J., Horwitz, E. J., Kusek, J. W., et al. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.12.025 · Cited by 37
Self-citationIimori, S., Noda, Y., Okado, T., Naito, S., Toda, T., Chida, Y., Kuwahara, M., Ando, R., Nishio, Y., Maeda, Y., et al. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-152 · Cited by 37
“Keeping such differences in mind, at the completion of the enrollment, we addressed whether the basic characteristics of ROUTE patients are different from those of Western cohorts, such as those in the CRIC study in the US [20,21], CRISIS study in UK [22], and MERENA study in Spain [23].”
Lash, J. P., Ricardo, A. C., Roy, J. A., Deo, R., Fischer, M. J., Flack, J., He, J., Keane, M. G., Lora, C. M., Ojo, A., et al. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.03.429 · Cited by 37
Self-citationMuiru, A. N., Hsu, J. Y., Zhang, X., Appel, L. J., Chen, J., Cohen, D. L., Drawz, P. E., Freedman, B. I., Go, A. S., He, J., et al. (2023) · Annals of Internal Medicine · doi:10.7326/m22-3617 · Cited by 39
Self-citationChua, H., Lau, T., Luo, N., Ma, V., Teo, B. W., Haroon, S. W. P., Choy, K.-L., Lim, Y.-C., Chng, W.-Q., Ong, L., et al. (2014) · Blood Purification · doi:10.1159/000357640 · Cited by 37
Parekh, R. S., Meoni, L. A., Jaar, B. G., Sozio, S. M., Shafi, T., Tomaselli, G. F., Lima, J. A. C., Tereshchenko, L. G., Estrella, M. M., & Kao, W. H. L. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0050-4 · Cited by 38
“Data collected from questionnaires have primarily used standardized, validated, and reliable questionnaires similar to the Chronic Renal Insufficiency Cohort (CRIC) Study [63,64].”
MethodInfluentialStatistical Methods for Cohort Studies of CKD: Prediction Modeling
Roy, J. A., Shou, H., Xie, D., Hsu, J. Y., Yang, W. P., Anderson, A. H., Landis, J. R., Jepson, C., He, J., Liu, K. D., et al. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06210616 · Cited by 37
Self-citationBansal, N., Zelnick, L. R., Soliman, E. Z., Anderson, A. H., Christenson, R. H., deFilippi, C. R., Deo, R., Feldman, H. I., He, J., Ky, B., et al. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.09.021 · Cited by 36
Self-citationAssociation Between Progression of Retinopathy and Concurrent Progression of Kidney Disease
Grunwald, J. E., Pistilli, M., Ying, G., Daniel, E., Maguire, M. G., Xie, D., Roy, J. A., Martin, R., Ostroff, C. P., Lo, J. C.-M., et al. (2019) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2019.1052 · Cited by 35
Self-citationCardiac Biomarkers and Risk of Mortality in CKD (the CRIC Study)
Wang, K., Zelnick, L. R., Anderson, A. H., Cohen, J., Dobre, M., Deo, R., Feldman, H., Go, A., Hsu, J. Y., Jaar, B., et al. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.08.028 · Cited by 30
Self-citationHossain, M. P., Palmer, D., Goyder, E., & Nahas, A. M. E. (2012) · Nephron Clinical Practice · doi:10.1159/000334998 · Cited by 34
Cardiac Resynchronization Therapy in CKD
Garg, N., Thomas, G., Jackson, G. R., Rickard, J., Nally, J. V., Tang, W. H. W., & Navaneethan, S. D. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00750113 · Cited by 34
Tang, M., Berg, A. H., Rhee, E. P., Allegretti, A. S., Nigwekar, S. U., Karumanchi, S. A., Lash, J. P., & Kalim, S. (2022) · Diabetes Care · doi:10.2337/dc22-1399 · Cited by 34
Self-citationSymptoms Characteristic of Heart Failure Among CKD Patients Without Diagnosed Heart Failure
Shlipak, M. G., Lash, J. P., Yang, W. P., Teal, V. L., Keane, M. G., Cappola, T., Keller, C., Jamerson, K., Kusek, J. W., Delafontaine, P., et al. (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.08.009 · Cited by 34
“The National Institute of Diabetes and Digestive and Kidney Diseases established CRIC in 2001 as an observation study to evaluate the determinants of progression to ESRD and CVD among persons with CKD.8,9 Participants were recruited from 7 clinical centers between July 2003 and March 2007.”
BackgroundInfluentialSelf-citationPaglialunga, S., Offman, E., Ichhpurani, N., Marbury, T., & Morimoto, B. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1274651 · Cited by 27
Central Blood Pressure and Cardiovascular Outcomes in Chronic Kidney Disease
Rahman, M., Hsu, J. Y., Desai, N. B., Hsu, C., Anderson, A. H., Appel, L. J., Chen, J., Cohen, D. L., Drawz, P. E., He, J., et al. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08620817 · Cited by 33
Self-citationRetinopathy and Progression of CKD
Grunwald, J. E., Pistilli, M., Ying, G., Daniel, E., Maguire, M. G., Xie, D., Martin, R., Ostroff, C. P., Lo, J. C.-M., Townsend, R. R., et al. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11761113 · Cited by 33
Self-citationHishida, M., Tamai, H., Morinaga, T., Maekawa, M., Aoki, T., Tomida, H., Komatsu, S., Kamiya, T., Maruyama, S., Matsuo, S., et al. (2016) · Clinical and Experimental Nephrology · doi:10.1007/s10157-015-1206-z · Cited by 33
Elevated lipoxygenase and cytochrome P450 products predict progression of chronic kidney disease
Afshinnia, F., Zeng, L., Byun, J., Wernisch, S., Deo, R., Chen, J., Hamm, L. L., Miller, E. R., Rhee, E. P., Fischer, M. J., et al. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy232 · Cited by 32
Self-citationRouabhi, M., Durieux, J., Al-Kindi, S. G., Cohen, J. B., Townsend, R. R., & Rahman, M. (2021) · Kidney Medicine · doi:10.1016/j.xkme.2020.10.012 · Cited by 32
Self-citationAssociation of Mitochondrial DNA Copy Number with Risk of Progression of Kidney Disease
He, W. J., Li, C., Huang, Z., Geng, S., Rao, V. S., Kelly, T. N., Hamm, L. L., Grams, M. E., Arking, D. E., Appel, L. J., et al. (2022) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.15551121 · Cited by 32
Self-citationBruinius, J. W., Hannan, M. F., Chen, J., Brown, J. J., Kansal, M. M., Meza, N., Saunders, M. R., He, J., Ricardo, A. C., Lash, J. P., et al. (2022) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2022.05.007 · Cited by 33
Self-citationRicardo, A. C., Lash, J. P., Fischer, M. J., Lora, C. M., Budoff, M. J., Keane, M. G., Kusek, J. W., Martinez, M. J. G., Nessel, L. C., Stamos, T. D., et al. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11341210 · Cited by 31
Self-citationPatterns of NSAIDs Use and Their Association with Other Analgesic Use in CKD
Zhan, M., Peter, W. L. S., Doerfler, R. M., Woods, C. M., Blumenthal, J. B., Diamantidis, C. J., Hsu, C., Lash, J. P., Lustigova, E., Mahone, E. B., et al. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12311216 · Cited by 31
Self-citationSim, J. J., Zhou, H. C., Shi, J. M., Shaw, S. F., Henry, S. L., Kovesdy, C. P., Kalantar‐Zadeh, K., & Jacobsen, S. J. (2018) · International Urology and Nephrology · doi:10.1007/s11255-018-1837-6 · Cited by 31
“In addition, late-stage CKD cohort studies often pool information from different data sources and clinical care environments, potentially limiting the interpretation of findings [12, 13].”
BackgroundVerma, A., Chitalia, V. C., Waikar, S. S., & Kolachalama, V. B. (2021) · Kidney Medicine · doi:10.1016/j.xkme.2021.04.012 · Cited by 31
“It is noteworthy that there are ongoing efforts to integrate machine learning in the Kidney Precision Medicine Project, 23 the Chronic Renal Insufficiency Cohort (CRIC) study, 24-26 the Cure Glomerulonephropathy (CureGN) study, 27 and the Nephrotic Syndrome Study Network (NEPTUNE).”
BackgroundYamamoto, Y., Hanai, K., Mori, T., Yokoyama, Y., Yoshida, N., Murata, H., Shinozaki, T., & Babazono, T. (2021) · Diabetologia · doi:10.1007/s00125-021-05590-5 · Cited by 32
Bundy, J. D., Rahman, M., Matsushita, K., Jaeger, B. C., Cohen, J. B., Chen, J., Deo, R., Dobre, M. A., Feldman, H. I., Flack, J. M., et al. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021060747 · Cited by 33
Self-citationTaal, M. W., Lucas, B. J., Roderick, P. J., Cockwell, P., Wheeler, D. C., Saleem, M. A., Fraser, S. D., Banks, R. E., Johnson, T. S., Hale, L. J., et al. (2023) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfad110 · Cited by 33
“Comparison with large national cohort studies from other countries including the Chronic Renal Insufficiency Cohort (CRIC) from the USA [ 16 ], Chronic Kidney Disease Japan Cohort (CKD-JAC) [ 17 ], Canadian study of prediction of death, dialysis and interim cardiovascular events (CanPREDDICT) [ 18…”
ResultPlantinga, L. (2013) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2012.07.361 · Cited by 31
Mishra, R., Yang, W. P., Roy, J. A., Anderson, A. H., Bansal, N., Chen, J., deFilippi, C. R., Delafontaine, P., Feldman, H. I., Kallem, R. R., et al. (2015) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002097 · Cited by 31
Self-citationTreatment Adherence in CKD and Support From Health care Providers: A Qualitative Study
Rivera, E., Clark‐Cutaia, M. N., Schrauben, S. J., Townsend, R. R., Lash, J. P., Hannan, M. F., Jaar, B. G., Rincon-Choles, H., Kansal, S. K., He, J., et al. (2022) · Kidney Medicine · doi:10.1016/j.xkme.2022.100545 · Cited by 39
“CRIC is a longitudinal nationwide CKD cohort study; study design and cohort characteristics have been described previously.(17,18) On inclusion into the CRIC cohort, participants must be above the age of 21 years and have a diagnosis of CKD stages 2-4.”
MethodSelf-citationChowdhury, M. N. H., Reaz, M. B. I., Ali, S. H. M., Crespo, M. L., Ahmad, S., Salim, G. M., Haque, F., Ordóñez, L. G. G., Islam, M., Mahdee, T. M., et al. (2025) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2025.103153 · Cited by 37
Bundy, J. D., Mills, K. T., Anderson, A. H., Yang, W., Chen, J., He, J., & CRIC Study Investigators* (2022) · Annals of Internal Medicine · doi:10.7326/m21-2928 · Cited by 32
“clinical centers between 2003 and 2008 with followup through May 2020 (16, 17).”
MethodSelf-citationPrediction of Incident Heart Failure in CKD: The CRIC Study
Zelnick, L. R., Shlipak, M. G., Soliman, E. Z., Anderson, A. H., Christenson, R. H., Kansal, M. M., Deo, R., He, J., Jaar, B. G., Weir, M. R., et al. (2022) · Kidney International Reports · doi:10.1016/j.ekir.2022.01.1067 · Cited by 31
Self-citationEngelbertz, C. M., Reinecke, H., Breithardt, G., Schmieder, R. E., Fobker, M., Fischer, D., Schmitz, B., Pinnschmidt, H. O., Wegscheider, K., Pavenstädt, H. J., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.05.022 · Cited by 29
Imaizumi, T., Fujii, N., Hamano, T., Yang, W. P., Taguri, M., Kansal, M. M., Mehta, R. C., Shafi, T., Taliercio, J. J., Go, A. S., et al. (2023) · Kidney International · doi:10.1016/j.kint.2023.01.008 · Cited by 30
Self-citationBansal, N., McCulloch, C. E., Lin, F., Robinson‐Cohen, C., Rahman, M., Kusek, J. W., Anderson, A. H., Xie, D., Townsend, R. R., Lora, C. M., et al. (2016) · Kidney International · doi:10.1016/j.kint.2016.08.009 · Cited by 28
Self-citationCKD Self-management: Phenotypes and Associations With Clinical Outcomes
Schrauben, S. J., Hsu, J. Y., Rosas, S. E., Jaar, B. G., Zhang, X., Deo, R., Saab, G., Chen, J., Lederer, S., Kanthety, R., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.01.047 · Cited by 28
Self-citationAssociation of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations
Snitker, S., Doerfler, R. M., Soliman, E. Z., Deo, R., Peter, W. L. S., Kramlik, S., Fischer, M. J., Navaneethan, S. D., Delafontaine, P., Jaar, B. G., et al. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12991216 · Cited by 27
Self-citationBuhnerkempe, M., Prakash, V., Botchway, A., Adekola, B., Cohen, J. B., Rahman, M., Weir, M. R., Ricardo, A. C., & Flack, J. M. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15064 · Cited by 27
Self-citationHall, R. K., Blumenthal, J. B., Doerfler, R. M., Chen, J., Diamantidis, C. J., Jaar, B. G., Kusek, J. W., Kallem, K., Leonard, M. B., Navaneethan, S. D., et al. (2021) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.03.019 · Cited by 27
Self-citationMineral bone disease in autosomal dominant polycystic kidney disease
Gitomer, B. Y., Pereira, R. C., Salusky, I. B., Stoneback, J. W., Isakova, T., Cai, X., Dalrymple, L. S., Ofsthun, N. J., You, Z., Malluche, H. H., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.07.041 · Cited by 27
Provenzano, M., Nicola, L. D., Pena, M. J., Capitoli, G., Garofalo, C., Borrelli, S., Gagliardi, I., Antolini, L., & Andreucci, M. (2020) · The Nephron journals/Nephron journals · doi:10.1159/000508983 · Cited by 27
Kim, H., Anderson, C. A. M., Hu, E. A., Zheng, Z., Appel, L. J., He, J., Feldman, H. I., Anderson, A. H., Ricardo, A. C., Bhat, Z. Y., et al. (2021) · Journal of Nutrition · doi:10.1093/jn/nxab203 · Cited by 26
Self-citationDeoxycholic Acid and Risks of Cardiovascular Events, ESKD, and Mortality in CKD: The CRIC Study
Frazier, R. S., Cai, X., Lee, J. J., Bundy, J. D., Jovanovich, A. J., Chen, J., Deo, R., Lash, J. P., Anderson, A. H., Go, A. S., et al. (2021) · Kidney Medicine · doi:10.1016/j.xkme.2021.09.004 · Cited by 26
“The CRIC study is a multicenter prospective observational cohort of patients with CKD stages 2-4.(15,16) The main objective is to investigate risk factors for the development”
MethodSelf-citationEllam, T., Fotheringham, J., & Kawar, B. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft466 · Cited by 26
“The recruitment procedures and characteristics of the CRIC, MDRD and NHANES cohorts have been published previously [20–24].”
MethodAdded Value of Screening for CKD among the Elderly or Persons with Low Socioeconomic Status
Vart, P., Reijneveld, S. A., Bültmann, U., & Gansevoort, R. T. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09030914 · Cited by 26
Kim, H., Yoo, T., Choi, K. H., Oh, K., Lee, J., Kim, S. W., Kim, T. H., Sung, S. A., Han, S. H., & KNOW-CKD Group (2017) · Journal of Korean Medical Science · doi:10.3346/jkms.2017.32.2.231 · Cited by 26
“In line with this finding, the Dialysis Outcomes and Practice Patterns Study showed that the mortality rates in ESRD patients in the United States and Europe were significantly higher than those in Japan (23).”
BackgroundResultInfluentialMehta, R. C., Ning, H., Bansal, N., Cohen, J. B., Srivastava, A., Dobre, M. A., Michos, E. D., Rahman, M., Townsend, R. R., Seliger, S. L., et al. (2021) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2021.10.007 · Cited by 25
Self-citationEffects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by Sex
Yu, M., Vart, P., Jongs, N., Correa‐Rotter, R., Rossing, P. R., McMurray, J. J. V., Hou, F. F., Douthat, W., Khullar, D., Langkilde, A. M., et al. (2023) · Journal of General Internal Medicine · doi:10.1007/s11606-023-08397-9 · Cited by 28
Vitamin D Metabolic Ratio and Risks of Death and CKD Progression
Bansal, N., Katz, R., Appel, L. J., Denburg, M., Feldman, H. I., Go, A. S., He, J., Hoofnagle, A. N., Isakova, T., Kestenbaum, B. R., et al. (2019) · Kidney International Reports · doi:10.1016/j.ekir.2019.08.014 · Cited by 25
“28 (8) 37 (10) 67 (18) 36 (10) 29 (8) 4 (1)”
Self-citationMethods and rationale of the DISCOVER CKD global observational study
Pecoits‐Filho, R., James, G., Carrero, J. J., Wittbrodt, E. T., Fishbane, S. N., Sultan, A. A., Heerspink, H. J. L., Hedman, K., Kanda, E., Chen, H., et al. (2021) · Clinical Kidney Journal · doi:10.1093/ckj/sfab046 · Cited by 25
“DISCOVER CKD aims to address epidemiological gaps and to understand the disease trajectory of patients with CKD from different geographies, complementing other multinational [36, 37], national and regional CKD/kidney failure cohort studies [38-43] and registries, including initiatives to collect data for patients rece…”
BackgroundGenomic Disorders in CKD across the Lifespan
Verbitsky, M., Krishnamurthy, S. B., Krithivasan, P., Hughes, D., Khan, A., Marasà, M., Vena, N., Khosla, P., Zhang, J., Lim, T. Y., et al. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2022060725 · Cited by 25
Self-citationRetinopathy and Cognitive Impairment in Adults With CKD
Yaffe, K. S., Ackerson, L., Hoang, T. D. M., Go, A. S., Maguire, M. G., Ying, G., Daniel, E., Bazzano, L., Coleman, M., Cohen, D. L., et al. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.10.006 · Cited by 25
Self-citationKu, E., Yang, W. P., McCulloch, C. E., Feldman, H. I., Go, A. S., Lash, J. P., Bansal, N., He, J., Horwitz, E., Ricardo, A. C., et al. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.08.011 · Cited by 25
Self-citationAlkali supplementation as a therapeutic in chronic kidney disease: what mediates protection?
Mannon, E. C., & O'Connor, P. M. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00343.2020 · Cited by 25
Tian, L., Jaeger, B. C., Scialla, J. J., Budoff, M. J., Mehta, R. C., Jaar, B. G., Saab, G., Dobre, M. A., Reilly, M. P., Rader, D. J., et al. (2024) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2024.06.018 · Cited by 24
Self-citationInflammatory Markers and Incidence of Hospitalization With Infection in Chronic Kidney Disease
Ishigami, J., Taliercio, J. J., Feldman, H. I., Srivastava, A., Townsend, R. R., Cohen, D. L., Horwitz, E. J., Rao, P. S., Charleston, J. B., Fink, J. C., et al. (2019) · American Journal of Epidemiology · doi:10.1093/aje/kwz246 · Cited by 24
Self-citationNegrea, L. A., Delozier, S., Janes, J. L., Rahman, M., & Dobre, M. A. (2021) · Kidney Medicine · doi:10.1016/j.xkme.2020.10.010 · Cited by 24
“The study design and participants’ baseline characteristics have been previously described.(18,19) Between 2003 and 2015, a total of 5,499 participants aged 21 to 74 years with eGFRs of 20 to 70 mL/min/1.”
MethodSelf-citationChronic Kidney Disease Among Agricultural Workers in Taiwan: A Nationwide Population-Based Study
Chang, C.-J., & Yang, H. (2023) · Kidney International Reports · doi:10.1016/j.ekir.2023.09.004 · Cited by 26
“These are well-documented risk factors of CKD. 27,28 Lifestyle factors such as BMI and exercise habits may not necessarily indicate a causal relationship with CKD/CKDu, because it is dif fi cult to determine which factor occurred fi rst.”
BackgroundRisk Profile in Chronic Kidney Disease Stage 3: Older versus Younger Patients
McIntyre, N. J., Fluck, R., McIntyre, C. W., & Taal, M. W. (2011) · Nephron Clinical Practice · doi:10.1159/000329109 · Cited by 24
Kelly, T. N., Raj, D. S., Rahman, M., Kretzler, M., Kallem, R. R., Ricardo, A. C., Rosas, S. E., Tao, K., Xie, D., Hamm, L. L., et al. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv125 · Cited by 24
“A detailed description of the CRIC study design and participants has been reported previously [19, 20].”
MethodSelf-citationPallikadavath, S., Ashton, L., Brunskill, N. J., Burton, J. O., Gray, L. J., & Major, R. (2021) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab132 · Cited by 23
Rhee, E. P., Surapaneni, A., Zheng, Z., Zhou, L., Dutta, D., Arking, D. E., Zhang, J., Duong, T., Chatterjee, N., Luo, S., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.01.014 · Cited by 21
Self-citationJanus, S. E., Hajjari, J., Chami, T., Mously, H., Badhwar, A., Karnib, M., Carneiro, H. A., Rahman, M., & Al-Kindi, S. G. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2543 · Cited by 23
Self-citationProtein Carbamylation and the Risk of ESKD in Patients with CKD
Kalim, S., Zhao, S. J., Tang, M., Rhee, E. P., Allegretti, A. S., Nigwekar, S. U., Karumanchi, S. A., Lash, J. P., & Berg, A. H. (2023) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000078 · Cited by 26
Self-citationEffect of Sodium Bicarbonate on Systolic Blood Pressure in CKD
Beynon-Cobb, B., Louca, P., Hoorn, E. J., Menni, C., & Padmanabhan, S. (2023) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000000000119 · Cited by 24
Metadata
- Authors
- Lash, J. P., Go, A. S., Appel, L. J., He, J., Ojo, A., Rahman, M., Townsend, R. R., Xie, D., Cifelli, D., Cohan, J., Fink, J. C., Fischer, M. J., Gadegbeku, C., Hamm, L. L., Kusek, J. W., Landis, J. R., Narva, A., Robinson, N., Teal, V., & Feldman, H. I.
- Affiliations
- University of Illinois Chicago (US)
- Kaiser Permanente (US)
- Johns Hopkins University (US)
- Tulane University (US)
- University of Michigan (US)
- University of Maryland, Baltimore (US)
- Edward Hines, Jr. VA Hospital (US)
- National Institutes of Health (US)
- Corresponding author
- Lash, James P.
- Rahman, Mahboob
- Cohan, Janet
- Fischer, Michael J.
- Kusek, John W.
- Narva, Andrew
- ORCID
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2009-08
- Volume
- 4
- Issue
- 8
- Pages
- 1302-1311
- ISSN
- 1555-9041 (ISSN-L)
- PMC
- PMC2723966
- OpenAlex
- W2160134719
- Cited by
- 619
- References
- 52
- Citations by year
- 2026: 37 · 2025: 36 · 2024: 42 · 2023: 40 · 2022: 58 · 2021: 52 · 2020: 51 · 2019: 39 · 2018: 34 · 2017: 32 · 2016: 48 · 2015: 34 · 2014: 27 · 2013: 37 · 2012: 23
- FWCI
- 11.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k24dk002651-10)
- University of Illinois at Urbana-Champaign
- National Institute of Diabetes and Digestive and Kidney Diseases (5U01DK06102, 5K24DK002651, R01DK072231, K24-DK002651, U01DK060990, 5U01 DK60980, T32DK060455, U01DK060984, U01DK060902, U01DK060980, U01DK060963, U01DK061021, U01DK061028)
- National Center for Research Resources (UL1RR024131, RR-05096, UL1RR024989, UL1RR025005, M01RR013987, M01RR016500, M01RR-013987-06, UL1RR024986, M01RR005096, M01 RR-024986, M01RR 16500, M01RR000042)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- chronic kidney disease, estimated glomerular filtration rate, cardiovascular disease, chronic kidney disease progression, risk factors, socioeconomic status, educational attainment, hypertension, diabetes mellitus, proteinuria, peripheral arterial disease, smoking, quality of life, functional status, CRIC study
- MeSH terms
- Adult, Age Factors, Aged, Blood Pressure, Cardiovascular Diseases, Educational Status, Female, Glomerular Filtration Rate, Humans, Kidney, Kidney Failure, Chronic, Male, Middle Aged, Prospective Studies, Proteinuria, Risk Factors, Smoking, Social Class, United States, Disease Progression, Risk Assessment, Patient Selection, Renal Insufficiency, Chronic, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
